Conditions: Allergic Rhinitis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 716
Healthy volunteers: no

Brief summary:
This study will investigate the effectiveness of desloratadine in treating subjects with allergic rhinitis who meet the criteria for persistent allergic rhinitis (PER)

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: 5-mg Desloratadine intervention 2: Placebo tablet
Intervention descriptions: intervention 1: 5-mg Desloratadine tablet, once daily for 12 weeks intervention 2: Placebo tablet, once daily for 12 weeks

Protocol document: